Higher Doses Of Radiation For Prostate Cancer Do Not Decrease Sexual Function, Study Finds

On account of of this precision, physicians can enlargement the potion of radiation, which is shown to cure else prostate cancers, without increasing side thing of radiation such as rectal bleeding, cramps or diarrhea. Sexual dysfunction can be a decision of radiation treatment for prostate cancer," said Site Buyyounouski, M.D., Fox Chase Cancer Centre and cause author of this study.

As a result, added radiation dose can be delivered to the prostate by increasing the dimensions of radiation everyone day. Increasing the radiation used each time is expressly charming due to it further shortens the treatment future by assorted days.

We commitment to constitute positive there's a balance between risk and benefit, and sexual servicing is a higher consideration. Fortunately, this glance at shows no reduce in sexual work from the higher doses of radiation." IMRT planning was used in both arms. Men who received androgen-deprivation therapy were excluded from the analysis. Sexual advantage was reported by patients using questionnaires before treatment and at six, 12 and 24 months after treatment.

Seventy-seven men received the seven and a half week treatment and 78 men received the shorter regimen with higher diurnal dose. There was no compelling discongruity in sexual service scores between the two groups at six, 12 months or 24 months closest treatment. Older date and poorer sexual assistance prior to treatment were related to a decline in sexual avail after treatment.

The shorter arm was not associated with erection factor or closeness at two years. There continued to be no differentiation in sexual supply between the two groups at six, 12 or 24 months" concluded Buyyounouski. Men who had low sexual utility before treatment were most doable to corner a decline in sexual overhaul after treatment.. Increasing radiation dose with hypofractionation and IMRT does not arrive to accumulation that risk."

This probation was presented at the American Sovereign state for Therapeutic Radiology and Oncology's 49th Annual Competition in Los Angeles. In appendix to Buyyounouski, other authors allow for Tianyu Li, Eric. M. Horwitz, M.D., Alan Pollack, M.D., Ph.D., Fox Chase Cancer Center and Deborah Watkins-Bruner, R.N.,

University of Pennsylvania. Adapted from materials if by Fox Chase Cancer Center.